OncoHost Ltd.
Biomed — Stage: Initial Revenues. Est: 2017. Tags: Analysis, Artificial Intelligence, Bioinformatics, Biotechnology, Cancer, Diagnostics, Life Sciences, Machine Learning, MedTech, Oncology. OncoHost is a technology company, transforming the approach to precision medicine for improved patient outcomes. OncoHost's proprietary platform, PROphet®, is a plasma-based, proteomic pattern analysis tool that uses a single blood sample to guide immunotherapy decision-making. Its first commercial offering, PROphetNSCLC®, supports first-line treatment decisions in metastatic non-small cell lung cancer (NSCLC) by providing clinically actionable insights that extend beyond tumor-only biomarkers.. Web: https://oncohost.com